Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers provide new insights into how common cold virus infects

On average, each of us catches a cold two to three times a year. However, how the common cold virus actually infects us is only partly understood. Researchers from the Max F. Perutz Laboratories of the Medical University of Vienna and the University of Vienna, in collaboration with two Spanish groups, have now provided new insights into this process.

30 Dec 2013

Streptococcus biofilms persist on objects, surfaces in daycare center for longer periods after cleaning

Numerous scientific studies have concluded that two common bacteria that cause colds, ear infections, strep throat and more serious infections cannot live for long outside the human body.

27 Dec 2013

CEL-SCI closes public offering of common stock, exercises over-allotment option to purchase additional shares

CEL-SCI Corporation, a late-stage oncology company, today announced that it has closed an underwritten public offering of units consisting of an aggregate of 5,238,095 shares of common stock and warrants to purchase an aggregate of 5,238,095 shares of common stock. The

27 Dec 2013

Dietitians identify 14 diet, nutrition and food trends to shape Americans' waistlines in 2014

The annual nutrition expert trends forecast is in – what fad diets are hot? What's out? Which foods top the list? What are consumers eating? According to a survey of more than 500 Registered Dietitians conducted by the nutrition trade magazine, Today's Dietitian, and a leading food, health and wellness public relations agency, Pollock Communications, America's demand for nutrition information is at an all-time high and there's no shortage of outlets talking about diets.

27 Dec 2013

Study explores how genetic sequencing can help fight new strains of flu

Published in the Journal Proceedings of the National Academy of Sciences, senior author, Associate Professor Katherine Kedzierska from the Department of Microbiology and Immunology said that being able to predict which patients will be more susceptible to the emerging influenza strain, will allow clinicians to better manage an early intervention strategy.

24 Dec 2013

Duration of common pediatric respiratory infections estimated

An international research team has systematically reviewed the literature to formulate up-to-date estimates of the duration of common childhood respiratory tract infections.

24 Dec 2013

Study finds link between genes affected by testosterone and antibody responses to influenza vaccine

A new study has identified a link between certain genes affected by testosterone and antibody responses to an influenza vaccine. The findings, published in Proceedings of the National Academy of Sciences, suggest that testosterone levels may partially explain why men often have weaker responses to vaccines than women.

24 Dec 2013

Research findings reveal how immune system responds to respiratory viral infections

An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute at Nationwide Children's Hospital, not only offer a new approach to treating the flu, but also add new information about how the immune system responds to respiratory viral infections.

24 Dec 2013

Reflux disease diagnosis: an interview with Professor Peter Dettmar, Managing Director of RD Biomed Limited

Generally speaking, reflux has been a major chronic issue for probably the last 40 or 50 years. When you look at the global population, depending on which country we're talking about, around 20% to 40% of individuals have reflux disease within their populations.

23 Dec 2013

FDA grants QIDP and Fast Track designations to TaiGen's nemonoxacin

TaiGen Biotechnology Company, Limited today announced that the U.S. Food and Drug Administration has granted nemonoxacin (Taigexyn) Qualified Infectious Disease Product and Fast Track designations for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

23 Dec 2013

Researchers develop new vaccine that protects against lethal pneumonia caused by staph bacteria

University of Iowa researchers have developed a new vaccine that protects against lethal pneumonia caused by Staphylococcus aureus (staph) bacteria, including drug-resistant strains like MRSA.

23 Dec 2013

Psychiatrist offers tips for dealing with holiday stress and sadness problems of the season

During the holidays, the goal should be to set the course somewhere "between Hallmark and heartache," a Vanderbilt psychiatrist says. In other words, don't strive for the perfect (you won't achieve it), and recognize and deal head-on with some of the stressors of the season.

23 Dec 2013

SLU nursing faculty, students receive special training to operate Closed Point of Dispensing

In the case of a bioterror attack, Saint Louis University will operate a medication dispensing station for students, faculty, staff and their families, offering quick access to medicines and easing the burden on local health departments so they can serve residents who lack similar access to lifesaving drugs.

22 Dec 2013

CSA Medical announces closing of $16 million Series C financing

CSA Medical, Inc., the leading provider of advanced spray cryotherapy technology that flash freezes unwanted tissue inside the body, today announced that it has closed a $16 million Series C financing led by Ascension Ventures.

20 Dec 2013

Autoimmune clue to narcolepsy

Researchers have identified immune cells in patients with narcolepsy that react against hypocretin, the lack of which causes the disorder.

20 Dec 2013

Physician dispels misconceptions about annual flu vaccine

Dr. Jennifer Caudle is an assistant professor of Family Medicine at the Rowan University School of Osteopathic Medicine. Over the years in her busy medical practice, she's heard just about every possible excuse or misconception about the annual flu vaccine.

20 Dec 2013

Biocryst seeks FDA NDA approval for Peramivir to treat influenza

BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.

20 Dec 2013

Walgreen's net earnings increase $695M to 68.3% in fiscal 2014 first quarter

Walgreen Co. today announced earnings and sales results for the first quarter of fiscal year 2014 ended Nov. 30. Net earnings determined in accordance with generally accepted accounting principles (GAAP) for the fiscal 2014 first quarter were $695 million, a 68.3 percent increase from $413 million in the year-ago quarter.

20 Dec 2013

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint

Amgen today announced that the Phase 3 DESCARTES (Durable Effect of PCSK9 Antibody CompARed wiTh PlacEbo Study) study evaluating the long-term 52-week safety and efficacy of evolocumab for the treatment of high cholesterol met its primary endpoint of percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week 52.

20 Dec 2013

New American Journal of Public Health issue explores methods, practices to enhance birth outcomes

In a new issue of the American Journal of Public Health, researchers and experts investigate the latest methods and practices in improving birth outcomes. The special issue compiles a collection of commentaries, research studies and editorials to discuss maternal and child health topics ranging from disparities to breastfeeding.

20 Dec 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers provide new insights into how common cold virus infects

Streptococcus biofilms persist on objects, surfaces in daycare center for longer periods after cleaning

CEL-SCI closes public offering of common stock, exercises over-allotment option to purchase additional shares

Dietitians identify 14 diet, nutrition and food trends to shape Americans' waistlines in 2014

Study explores how genetic sequencing can help fight new strains of flu

Duration of common pediatric respiratory infections estimated

Study finds link between genes affected by testosterone and antibody responses to influenza vaccine

Research findings reveal how immune system responds to respiratory viral infections

Reflux disease diagnosis: an interview with Professor Peter Dettmar, Managing Director of RD Biomed Limited

FDA grants QIDP and Fast Track designations to TaiGen's nemonoxacin

Researchers develop new vaccine that protects against lethal pneumonia caused by staph bacteria

Psychiatrist offers tips for dealing with holiday stress and sadness problems of the season

SLU nursing faculty, students receive special training to operate Closed Point of Dispensing

CSA Medical announces closing of $16 million Series C financing

Autoimmune clue to narcolepsy

Physician dispels misconceptions about annual flu vaccine

Biocryst seeks FDA NDA approval for Peramivir to treat influenza

Walgreen's net earnings increase $695M to 68.3% in fiscal 2014 first quarter

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint

New American Journal of Public Health issue explores methods, practices to enhance birth outcomes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in